5

Tonira Pharma Ltd(merged)

530155 BSE
This stock has been delisted or merged and is no longer actively traded.

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Debtor days have improved from 64.2 to 46.3 days.

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 0.12% over past five years.
  • Company has a low return on equity of 1.45% over last 3 years.

Growth Rate

Revenue Growth
-18% lower than 3Y
Net Income Growth
-300% lower than 3Y

Quarterly Results

Particulars Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales
99
134
122
103
106
146
88
98
89
100
96
99
105
Expenses
75
111
97
77
82
125
62
73
62
68
67
77
83
Operating Profit
24
23
25
25
24
21
25
25
27
32
29
22
22
OPM %
24%
17%
21%
25%
23%
14%
29%
25%
30%
32%
30%
22%
21%
Other Income
2
1
3
2
2
7
4
5
4
-40
4
17
8
Interest
2
0
3
1
0
1
1
2
1
2
2
1
1
Depreciation
4
5
5
5
5
6
6
6
6
6
6
6
6
PBT
20
20
21
21
21
21
22
22
24
-16
25
32
22
Tax %
27%
25%
26%
27%
23%
32%
25%
25%
24%
-18%
28%
25%
27%
Net Profit
15
15
15
16
16
14
16
16
18
-13
18
24
16
EPS in Rs
2.23
2.26
2.38
2.29
2.36
1.99
2.28
2.29
2.55
-1.83
2.52
3.3
2.24
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Sales
29.86
36.55
28.61
38.47
36.82
30.04
Expenses
23.59
29.67
29.55
30.18
29.97
26.31
Operating Profit
6.27
6.88
-0.94
8.29
6.85
3.73
OPM %
21%
18.82%
-3.29%
21.55%
18.6%
12.42%
Other Income
0.1
0.2
-3.37
-2.24
0.21
0.28
Interest
1.25
1.81
2.1
3.6
2.88
3.14
Depreciation
2.44
2.57
2.77
2.8
2.84
3.07
PBT
2.68
2.7
-9.18
-0.35
1.34
-2.2
Tax %
35.82%
39.26%
-36.49%
111.43%
23.88%
-5.45%
Net Profit
1.72
1.64
-5.83
-0.74
1.02
-2.08
Div. Payout %
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Equity Capital
7.94
7.94
7.94
7.94
7.94
7.94
Reserves
10.49
12.13
6.3
5.25
6.39
4.31
Borrowings
21.41
19.68
28.91
28.38
31.3
36.74
Other Liabilities
6.1
10.13
8.97
11.47
8.06
6.62
Total Liabilities
45.94
49.88
52.12
53.04
53.69
55.61
Fixed Assets
27.3
27.79
26.21
24.13
24.55
23.41
CWIP
0
0
0.11
0.09
0.54
1.21
Investments
0.12
0.04
0.04
0.04
0.14
0.14
Other Assets
18.52
22.05
25.76
28.78
28.46
30.85
Total Assets
45.94
49.88
52.12
53.04
53.69
55.61
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Operating
-0.57
5.07
-4.71
3.81
7.45
-0.93
Investing
-5.62
-3.27
-1.17
-0.72
-3.82
-2.63
Financing
6.11
-1.72
7.1
-4.12
-1.1
2.7
Net Cash Flow
-0.08
0.08
1.22
-1.03
2.53
-0.86
Free Cash Flow
-6.07
1.8
-5.88
3.09
3.72
-3.56
CFO/OP
-8
74
501
47
115
-20
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Debtor Days
68.09
40.24
69.15
83.49
62.75
46.29
Inventory Days
316
345
248
256
233
360
Days Payable
120
138
142
180
130
119
Cash Conversion Cycle
264
248
175
160
166
288
Working Capital Days
158
130
173
148
164
257
ROCE %
—
11.36%
-7.6%
14.09%
9.68%
2.07%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tonira Pharma Ltd(merged) insights

57 extracted metrics + investor summaries across FY06–FY26.

Log in — free

Shareholding Pattern

DIIs0.76%Public56.78%FIIs3.45%Promot.39.01%As ofDec 2025

Documents

Frequently Asked Questions about Tonira Pharma Ltd(merged)

Where is Tonira Pharma Ltd(merged) (530155) listed?
Tonira Pharma Ltd(merged) trades under code 530155 on the BSE.
Which sector does Tonira Pharma Ltd(merged) belong to?
Tonira Pharma Ltd(merged) is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Website tonira.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530155.md for Tonira Pharma Ltd(merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List